Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | CCKBR | P32239 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24746668 | 0.94 | ALDH1A1 (0.44) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL24746667 | 0.89 | ALDH1A1 (0.43) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL24746656 | 0.89 | ALDH1A1 (0.45) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL24746986 | 0.87 | OPRM1 (0.38) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL19388140 | 0.82 | OPRM1 (0.41) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL25857137 | 0.82 | OPRM1 (0.41) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL25857125 | 0.81 | ALDH1A1 (0.51) | ALDH1A1OPRM1OPRD1OPRK1NPC1 | |
| SCHEMBL18666981 | 0.79 | OPRM1 (0.47) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL22863834 | 0.79 | OPRM1 (0.47) | ALDH1A1OPRM1OPRD1OPRK1AKT1 | |
| SCHEMBL24746660 | 0.79 | ALDH1A1 (0.51) | ALDH1A1OPRM1OPRD1OPRK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11801228-B2 | Modified guanidine-containing polymers for biologic delivery | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230225982-A1 | MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-07-20 | — | — | US | disclosed |
| US-11529315-B1 | Modified guanidine-containing polymers for biologic delivery | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225982-A1 | MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY | GMPS, RNMT, GUCY1A1 | ALDH1A1 1829/4885OPRM1 2522/4885OPRD1 3897/4885 |
| US-11801228-B2 | Modified guanidine-containing polymers for biologic delivery | GMPS, RNMT, GUCY1A1 | ALDH1A1 1829/4885OPRM1 2522/4885OPRD1 3897/4885 |
| US-11529315-B1 | Modified guanidine-containing polymers for biologic delivery | GMPS, RNMT, GUCY1A1 | ALDH1A1 1829/4885OPRM1 2522/4885OPRD1 3897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.